<DOC>
	<DOCNO>NCT00277043</DOCNO>
	<brief_summary>The purpose study determine whether test dose program taxanes reduce rate and/or severity hypersensitivity reaction ( HSR ) ; determine whether test dose program taxanes result cost reduction due decrease drug wastage .</brief_summary>
	<brief_title>A Phase III Randomized Trial Assessing Utility Test Dose Program With Taxanes</brief_title>
	<detailed_description>Patients randomize one two arm : 1 . Test dose arm 1 mg paclitaxel docetaxel test dose prepare 3 ml normal saline administer two five minute IV push least 30 minute prescribe IV PO pre-medications . If discernable adverse reaction ensues , balance taxane dose prepare administer per standard specific chemotherapy protocol . 2 . Non test dose arm The full taxane dose prepare administer per standard specific chemotherapy protocol , least 30 minute prescribe IV PO pre-medications .</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<criteria>Patient must sign informed consent Patient must great 18 year age Patient must receive his/her first dose either Taxol Taxotere Patient must receive routine premedications hypersensitivity reaction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Taxane</keyword>
	<keyword>Test Dose</keyword>
</DOC>